期刊文献+

SELDI-TOF-MS技术在消化道肿瘤早期诊断中的应用

SELDI-TOF-MS technology and its application in the early diognosis of digestive systemic cancer
下载PDF
导出
摘要 蛋白质组学技术的发展为发现新的生物标记物提供了机会。表面增强激光解析电离飞行时间质谱(Surface enhanced laser desorption/ionization time-of-flight masss pectrometry)就是一种新兴的有发展前途的蛋白质组技术。此文就其在消化道肿瘤早期诊断研究中的应用作一综述。 Recent advances in proteomics offer opportunities to rapidly identify new biomarkers or pattern of markers for early diagnosis of cancer. The surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) is one of the most promising approaches to achieve the goal. This article introduces the application of the new technology in the early diognosis of digestive systemic cancers.
作者 蒋黎 张顺财
出处 《国际消化病杂志》 CAS 2007年第2期142-144,共3页 International Journal of Digestive Diseases
关键词 蛋白质组 表面增强激光解吸/电离飞行时间质谱 消化道肿瘤 生物标记 Proteome SELDI-TOF-MS Digestive systemic cancer Biomarkers
  • 相关文献

参考文献7

二级参考文献81

  • 1Jie-KaiYu,Yi-DingChen,ShuZheng.An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics[J].World Journal of Gastroenterology,2004,10(21):3127-3131. 被引量:30
  • 2秦艳茹,王立东,邝丽芸,关新元,庄则豪,范宗民,邓文,曹世华.食管癌原发灶与淋巴结转移灶细胞染色体变化特征的比较[J].癌症,2005,24(9):1048-1053. 被引量:7
  • 3[1]Pisani P,Parkin DM,Bray F,Ferlay J.Estimates of the worldwide mortality from 25 cancers in 1990.Int J Cancer 1999;83:18-29
  • 4[2]Murray CJ,Lopez AD.Alternative projections of mortality and disability by cause 1990-2020:Global Burden of Disease Study.Lancet 1997; 349:1498-1504
  • 5[3]Gaspar MJ,Arribas I,Coca MC,Diez-Alonso M.Prognostic value of carcinoembryonic antigen,CA 19-9 and CA 72-4 in gastric carcinoma.Tumour Biol 2001; 22:318-322
  • 6[4]Marrelli D,Roviello F,De Stefano A,Farnetani M,Garosi L,Messano A,Pinto E.Prognostic significance of CEA,CA 19-9and CA 72-4 preoperative serum levels in gastric carcinoma.Oncology 1999; 57:55-62
  • 7[5]Carpelan-Holmstrom M,Louhimo J,Stenman UH,Alfthan H,Haglund C.CEA,CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.Anticancer Res 2002; 22:2311-2316
  • 8[6]Takahashi Y,Takeuchi T,Sakamoto J,Touge T,Mai M,Ohkura H,Kodaira S,Okajima K,Nakazato H; Tumor Marker Committee.The usefulness of CEA and/or CA19-9in monitoring for recurrence in gastric cancer patients:a prospective clinical study.Gastric Cancer 2003; 6:142-145
  • 9[7]Issaq HJ,Conrads TP,Prieto DA,Tirumalai R,Veenstra TD.SELDI-TOF MS for diagnostic proteomics.Anal Chem 2003; 75:148-155
  • 10[8]Wiesner A.Detection of tumor markers with ProteinChip technology.Curr Pharm Biotechnol 2004; 5:45-67

共引文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部